Correlation Between Equillium and Entera Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Equillium and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Entera Bio, you can compare the effects of market volatilities on Equillium and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Entera Bio.

Diversification Opportunities for Equillium and Entera Bio

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Equillium and Entera is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of Equillium i.e., Equillium and Entera Bio go up and down completely randomly.

Pair Corralation between Equillium and Entera Bio

Allowing for the 90-day total investment horizon Equillium is expected to generate 2.71 times less return on investment than Entera Bio. In addition to that, Equillium is 1.07 times more volatile than Entera Bio. It trades about 0.03 of its total potential returns per unit of risk. Entera Bio is currently generating about 0.07 per unit of volatility. If you would invest  56.00  in Entera Bio on September 12, 2024 and sell it today you would earn a total of  167.00  from holding Entera Bio or generate 298.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Equillium  vs.  Entera Bio

 Performance 
       Timeline  
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Entera Bio 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Entera Bio are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Entera Bio showed solid returns over the last few months and may actually be approaching a breakup point.

Equillium and Entera Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Equillium and Entera Bio

The main advantage of trading using opposite Equillium and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.
The idea behind Equillium and Entera Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA